Trine Folseraas

7.7k total citations · 1 hit paper
37 papers, 1.2k citations indexed

About

Trine Folseraas is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Trine Folseraas has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hepatology, 24 papers in Surgery and 18 papers in Epidemiology. Recurrent topics in Trine Folseraas's work include Liver Diseases and Immunity (30 papers), Liver Disease Diagnosis and Treatment (17 papers) and Gallbladder and Bile Duct Disorders (16 papers). Trine Folseraas is often cited by papers focused on Liver Diseases and Immunity (30 papers), Liver Disease Diagnosis and Treatment (17 papers) and Gallbladder and Bile Duct Disorders (16 papers). Trine Folseraas collaborates with scholars based in Norway, Germany and United Kingdom. Trine Folseraas's co-authors include Tom H. Karlsen, Mette Vesterhus, Douglas Thorburn, Kirsten Muri Boberg, Brian K. Chung, Vincenzo Cardinale, Domenico Alvaro, Guido Carpino, Diletta Overi and Christian Rupp and has published in prestigious journals such as Hepatology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Trine Folseraas

32 papers receiving 1.2k citations

Hit Papers

Primary sclerosing cholangitis – a comprehensive review 2017 2026 2020 2023 2017 100 200 300 400 500

Peers

Trine Folseraas
Trine Folseraas
Citations per year, relative to Trine Folseraas Trine Folseraas (= 1×) peers Andrea Gardini

Countries citing papers authored by Trine Folseraas

Since Specialization
Citations

This map shows the geographic impact of Trine Folseraas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trine Folseraas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trine Folseraas more than expected).

Fields of papers citing papers by Trine Folseraas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trine Folseraas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trine Folseraas. The network helps show where Trine Folseraas may publish in the future.

Co-authorship network of co-authors of Trine Folseraas

This figure shows the co-authorship network connecting the top 25 collaborators of Trine Folseraas. A scholar is included among the top collaborators of Trine Folseraas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trine Folseraas. Trine Folseraas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holmer, Magnus, Michael Ingre, Martti Färkkilâ, et al.. (2025). Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study. Hepatology. 83(1). 21–29.
2.
Hov, Johannes R., Eystein S. Husebye, Trine Folseraas, et al.. (2025). Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology. 60(2). 165–173.
3.
Mol, Bregje, Martti Färkkilâ, Trine Folseraas, et al.. (2024). DOP14 Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international study. Journal of Crohn s and Colitis. 18(Supplement_1). i97–i98. 2 indexed citations
4.
Wacker, Eike Matthias, Florian Uellendahl-Werth, Olaf Wolkenhauer, et al.. (2023). Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis. JHEP Reports. 6(2). 100988–100988. 2 indexed citations
5.
Juran, Brian D., Ahmad H. Ali, Erik M. Schlicht, et al.. (2023). Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis. PubMed. 3(1). osac011–osac011. 2 indexed citations
6.
Medhus, Asle W., et al.. (2023). ERCP for the initial management of malignant biliary obstruction – real world data on 596 procedures. Endoscopy. 55(S 02). S152–S153.
7.
Folseraas, Trine, et al.. (2023). Primær skleroserende kolangitt. Tidsskrift for Den norske legeforening. 143(17).
8.
Nooijen, Lynn E., Jesús M. Bañales, Marieke T. de Boer, et al.. (2022). Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers. 14(10). 2389–2389. 16 indexed citations
9.
Lo, Bobby, Christoph Schramm, Olivier Chazouillères, et al.. (2022). Survey uncovering variations in the management of primary sclerosing cholangitis across Europe. JHEP Reports. 4(11). 100553–100553. 10 indexed citations
10.
Wiencke, Kristine, Ida Torunn Bjørk, Odd Helge Gilja, et al.. (2021). Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF. JHEP Reports. 3(5). 100328–100328. 21 indexed citations
11.
Aune, Dagfinn, Abhijit Sen, Teresa Norat, Elio Ríboli, & Trine Folseraas. (2021). Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies. Scientific Reports. 11(1). 10646–10646. 22 indexed citations
12.
Rupp, Christian, Annika Bergquist, Trine Folseraas, et al.. (2021). Associations of neopterin and kynurenine–tryptophan ratio with survival in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology. 56(4). 443–452. 9 indexed citations
13.
Mousa, Omar Y., Brian D. Juran, Bryan M. McCauley, et al.. (2020). Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation. Hepatology. 74(1). 281–295. 68 indexed citations
14.
Vedeld, Hege Marie, Trine Folseraas, & Guro E. Lind. (2020). Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers. JHEP Reports. 2(5). 100143–100143. 15 indexed citations
15.
Carpino, Guido, Vincenzo Cardinale, Trine Folseraas, et al.. (2018). Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis. Hepatology. 69(2). 622–638. 44 indexed citations
16.
Chung, Brian K., Tom H. Karlsen, & Trine Folseraas. (2017). Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1390–1400. 55 indexed citations
17.
Karlsen, Tom H., Trine Folseraas, Douglas Thorburn, & Mette Vesterhus. (2017). Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology. 67(6). 1298–1323. 527 indexed citations breakdown →
18.
Folseraas, Trine & Kirsten Muri Boberg. (2015). Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. Clinics in Liver Disease. 20(1). 79–98. 41 indexed citations
19.
Folseraas, Trine, Evaggelia Liaskou, Carl A. Anderson, & Tom H. Karlsen. (2014). Genetics in PSC: What Do the “Risk Genes” Teach Us?. Clinical Reviews in Allergy & Immunology. 48(2-3). 154–164. 27 indexed citations
20.
Wannhoff, Andreas, Johannes R. Hov, Trine Folseraas, et al.. (2013). FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. Journal of Hepatology. 59(6). 1278–1284. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026